logo-loader
Health

Expert view on Creo's tech

Expert view on Creo's tech Year end...

on 27/11/23
Health

Nanoviricides: COVID-19 therapy trial underway, RSV trial to follow

COVID-19 therapy trial underway, RSV trial to follow NanoViricides...

on 12/7/23
Health

Voyageur Pharmaceuticals: Earthly profits from contrasting media

Voyageur: Earthly profits from contrasting...

on 6/6/23
Mining

Advancing two large lithium clay targets

Advancing two large lithium clay...

on 20/4/23
Health

Voyageur Pharmaceuticals: New products, MRI developments and international deal

New products, MRI developments and international...

on 21/12/23
Health

Poolbeg Pharma Driving forward R&D programmes while seeking partners

Driving forward R&D programmes while seeking...

on 2/11/23
Mining

Sonoro Gold files its preliminary economic assessment

Sonoro Gold files its preliminary economic...

on 23/10/23
Finance

Sirius Real Estate: Steadfast growth amidst economic headwinds

Sirius Real Estate: Steadfast growth amidst economic...

on 10/10/23

NanoViricides makes progress as it completes dosing in Phase 1a COVID study

Proactive research analyst John Savin speaks to Stephen Gunnion after publishing a research note about the latest Covid trial from development-stage antiviral company NanoViricides (NYSE-A:NNVC). The company has successfully completed dosing in a Phase 1a COVID study, marking a major...

on 29/1/24